Current concepts of polycystic ovary syndrome (Q41736007)

8 October 2017

1 reference

title

Current concepts of polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

8 October 2017

main subject

1 reference

1 reference

Rosenfield RL

1 reference

8 October 2017

publication date

1 June 1997

1 reference

Bailliere's clinical obstetrics and gynaecology

8 October 2017

published in

1 reference

8 October 2017

1 reference

8 October 2017

1 reference

8 October 2017

page(s)

307-333

1 reference

Leptin is a metabolic signal to the reproductive system.

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The polycystic ovary syndrome: pathogenesis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Clinical review 78: Aromatase deficiency in women and men: would you have predicted the phenotypes?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin-like growth factor-I enhances luteinizing hormone binding to rat ovarian theca-interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Clinical implications of hyperinsulinaemia in women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Effects of luteinizing hormone, insulin, insulin-like growth factor-I and insulin-like growth factor small binding protein 1 in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Ovarian stromal hypertrophy in hyperandrogenic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Effect of obesity on conversion of plasma androstenedione to estrone in ovulatory and anovulatory young women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Detection of Functional Ovarian Hyperandrogenism in Women with Androgen Excess

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The zona reticularis is the site of biosynthesis of dehydroepiandrosterone and dehydroepiandrosterone sulfate in the adult human adrenal cortex resulting from its low expression of 3 beta-hydroxysteroid dehydrogenase.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Granulosa cells of polycystic ovaries: are they normal or abnormal?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The diagnosis of polycystic ovaries in women with oligo-amenorrhoea: predictive power of endocrine tests

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic ovary syndrome: a changing perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The polycystic ovary. I. Clinical and histologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The role of insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) in the pathogenesis of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Hyperinsulinemia in postpubertal girls with a history of premature pubarche and functional ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The genetics of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Adrenal androgen hyperresponsiveness to adrenocorticotropin in women with acne and/or hirsutism: adrenal enzyme defects and exaggerated adrenarche

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Trp64Arg mutation in beta 3-adrenoceptor gene of doubtful significance for obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Are women with polycystic ovary syndrome at special risk for coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Relationship between follicle-stimulating hormone, androstenedione and oestradiol in human follicular fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Relative effects of activin and inhibin on steroid hormone synthesis in primate granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Puberty and polycystic ovarian syndrome: the insulin/insulin-like growth factor I hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Increased risk for polycystic ovary syndrome associated with human leukocyte antigen DQA1*0501

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Obesity and its role in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Epidermal growth factor and the multiplication of cultured human epidermal keratinocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Are adrenal and ovarian function normal in true precocious puberty?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Role of androgens in the developmental biology of the pilosebaceous unit

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Through thick and thin: wasting, obesity, and TNF alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Does early physical maturity influence breast cancer risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Menstrual irregularities in adolescents: hormonal pattern and ovarian morphology.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Gonadotrophin and gonadal steroid response to a single dose of a long-acting agonist of gonadotrophin-releasing hormone in ovulatory and anovulatory women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Hormonal regulation of the growth and steroidogenic function of human granulosa cells

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2897%2980039-9

7 January 2021

10.1016/S0950-3552(97)80039-9

Identifiers

DOI

1 reference

8 October 2017

1 reference